<DOC>
	<DOCNO>NCT00830856</DOCNO>
	<brief_summary>Cryptococcal Meningitis continue one devastating AIDS define illness sub-Saharan Africa . Despite availability azoles fluconazole treatment , mortality remain high study show 100 % mortality . The investigator design study determine timing initiation antiretroviral therapy ( ART ) patient cryptococcal meningitis HIV would improve survival . The investigator hypothesis early initiation ART result improve mortality patient HIV cryptococcal meningitis .</brief_summary>
	<brief_title>Early Versus Delayed Antiretroviral Therapy ( ART ) Treatment Cryptococcal Meningitis Africa</brief_title>
	<detailed_description>Cryptococcosis invasive fungal infection cause encapsulate yeast . Cryptococcosis humans almost always cause Cryptococcus neoformans . The advent HIV epidemic lead profound increase number report case cryptococcal meningoencephalitis throughout world , particularly sub-Saharan Africa . In Zimbabwe analysis case report one major tertiary care hospital show increase admission rate meningitis 1985-1995 78 523 case per 100000 admission increase number case due cryptococcosis 5 % 46.2 % . Cryptococcosis typically develop CD4 count le 50 cells/ mm3 , initial AIDS defining illness 50-60 % patient . Prior introduction amphotericin B , flucytosine azoles , mortality C neoformans meningoencephalitis close 100 % . The introduction amphotericin B lead significant decrease mortality 60-70 % patient successfully treat . The introduction fluconazole prophylaxis 1990s lead significant decrease incidence cryptococcosis . The use antiretroviral therapy also cause significant decrease incidence cryptococcal meningitis . Due prohibitive cost amphotericin B flucytosine , many develop country Zimbabwe , mainstay treatment CM fluconazole . The current standard treatment fluconazole 400mg/day 8-10 week , may low result adequate CNS concentration drug achieve adequate kill C. neoformans . Clinically physicians Zimbabwe note patient respond adequately regimen start treat patient higher dos fluconazole . Previous study show high dos fluconazole use treatment CM well tolerate . In proposed study , patient treat high dose oral fluconazole 800mg/day total 10 week period . The advent increase access ART sub-Saharan Africa provide additional opportunity improve morbidity mortality AIDS patient . There yet definitive study indicate advantage immediate ART therapy set acute CM compare defer therapy first 10 week intensive CM therapy . This study design address question provide physician sub-Saharan Africa evidence base guideline appropriate management HIV positive patient acute presentation CM .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis , Cryptococcal</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<mesh_term>Stavudine</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<criteria>HIV infection document positive HIV antibody test enrollment ; Adult men woman ( age &gt; 18 ) ; Cryptococcal meningitis infection document positive CSF CRAG CSF identification C. neoformans . Place residence locate within 50km radius Harare . Previous diagnosis ( &gt; 1 week ) treatment cryptococcal meningitis Currently ARVs , intermittently ART past . Concurrent use medication affect metabolism fluconazole e.g. , antiseizure medication , oral hypoglycaemic agent . History cardiac failure predisposition arrhythmia exclude . They pregnant active lactation woman History active hepatitis hepatic renal dysfunction exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Cryptococcal Meningitis</keyword>
	<keyword>HIV</keyword>
	<keyword>Fluconazole</keyword>
	<keyword>Antiretroviral therapy</keyword>
	<keyword>Africa</keyword>
	<keyword>treatment naive</keyword>
</DOC>